Stress Management Program for Depression and Anxiety in Young Adults With Cancer
(PRISM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a stress management program called PRISM (Promoting Resilience in Stress Management Program), designed to help young adults manage depression and anxiety related to cancer or a desmoid tumor. The program includes six therapy sessions, either remotely or in person, with a psychologist to build resilience and manage stress. It suits those diagnosed with cancer or a desmoid tumor at least six weeks ago and who are either currently receiving treatment or finished treatment in the last six months. Participants should experience symptoms of depression or anxiety affecting their daily lives.
As an unphased trial, this study offers a unique opportunity to explore new ways to manage stress and improve mental health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that the PRISM Program is safe for young adults with cancer?
Research has shown that the Promoting Resilience in Stress Management (PRISM) program is well-received by young adults with cancer. Studies have found that PRISM boosts resilience, lowers distress, and improves quality of life. No reports of serious side effects have emerged from participating in this supportive program. This suggests that PRISM is a safe way to help manage stress, depression, and anxiety in young adults with cancer.12345
Why are researchers excited about this trial?
The Promoting Resilience in Stress Management (PRISM) program is unique because it offers a structured, psychological approach specifically tailored for young adults with cancer who are experiencing depression and anxiety. Unlike standard treatments that might rely heavily on medication or general therapy, PRISM combines flexibility with personalized care through remote or in-clinic sessions, focusing on building resilience. Researchers are excited about this treatment because it empowers patients to actively manage stress, potentially improving mental health outcomes and quality of life alongside their cancer treatment.
What evidence suggests that the PRISM Program is effective for managing depression and anxiety in young adults with cancer?
Research has shown that the Promoting Resilience in Stress Management (PRISM) Program, which participants in this trial will receive, can help young adults with cancer improve their mental health. In earlier studies, participants in PRISM felt more resilient and hopeful after three months. They also experienced less distress, feeling less worried or upset. The program includes coaching to teach skills for better stress management. These studies suggest that PRISM could effectively reduce symptoms of depression and anxiety in young adults dealing with cancer.36789
Who Is on the Research Team?
Samantha Bento, PhD
Principal Investigator
Dana-Farber Cancer Institute
Greta J Khanna, PhD, MA
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for young adults with cancer who are experiencing symptoms of depression and anxiety. The study aims to see if a program called PRISM can help manage these psychological symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and a diagnostic assessment of depressive and anxiety symptoms
Treatment
Participants undergo the PRISM intervention, consisting of 6 weekly or bi-weekly psychotherapy sessions
Post-Intervention Assessment
Participants complete final questionnaires and a post-study exit interview
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Promoting Resilience in Stress Management Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor